Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Mersana Therapeutics (MRSN) Q2 2025 Earnings
MRSN
15
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-4.81
-3.24
-1.66
-0.09
Details
Expected EPS
-4.813929
Actual EPS
-4.75
Surprise EPS
0.06
Surprise Percent
+1.33%
Description
Mersana Therapeutics (MRSN) has reported earnings of -4.75 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login